文献速递神经肌肉病

重复性眼性前庭诱发肌源性电位诊断上睑下垂或复视患者重症肌无力的准确性

Accuracy of Repetitive Ocular Vestibular-Evoked Myogenic Potentials to Diagnose Myasthenia Gravis in Patients With Ptosis or Diplopia.
PubMed 文献 · Neurology · 2024-04-26

该项盲法前瞻性诊断准确性试验纳入89例疑似眼肌型重症肌无力(OMG)的上睑下垂和/或复视患者,以多模态诊断作为参考标准,评估重复性眼性前庭诱发肌源性电位(roVEMP)的诊断准确性。roVEMP敏感度为88.2%、特异度30.2%、阳性预测值50%、阴性预测值76.5%;单纤维肌电图(SFEMG)敏感度75%、特异度56%、阳性预测值55.1%、阴性预测值75.7%。作者认为roVEMP敏感度高但特异度和阳性预测值过低,不能单独用于OMG诊断,多模态方法仍可获得最高诊断准确性。

要点

  • roVEMP诊断OMG的敏感度为88.2%,特异度为30.2%,阳性预测值为50%,阴性预测值为76.5%。
  • SFEMG的敏感度为75%,特异度为56%,阳性预测值为55.1%,阴性预测值为75.7%。
  • roVEMP不能单独准确区分MG与非MG疾病,多模态方法仍可获得最高诊断准确性。

核心结论

  • roVEMP在OMG中敏感度为88.2%,但特异度和阳性预测值过低,不能作为单一试验诊断OMG。
  • 区分眼肌型MG与其他神经眼科疾病仍有挑战,最高诊断准确性仍由多模态方法获得。
  • 在本研究中,roVEMP可作为MG诊断工具的补充。

研究设计与样本

  • 盲法前瞻性诊断准确性试验,连续纳入89例表现为上睑下垂和/或复视、疑似OMG的患者。
  • 以多模态诊断方法为参考,包括临床检查、抗体、依酚氯铵试验、副神经和面神经重复神经刺激及单纤维肌电图(SFEMG)。

主要发现

  • 完成诊断评估后,39例(44%)诊断为眼肌型MG,50例(56%)为非MG的其他神经眼科疾病。
  • roVEMP(30 Hz刺激范式,单侧递减>9%为 cutoff)敏感度88.2%、特异度30.2%、阳性预测值50%、阴性预测值76.5%。
  • SFEMG敏感度75%、特异度56%、阳性预测值55.1%、阴性预测值75.7%。
  • 除冰袋试验外,所有其他诊断试验在MG患者中的阳性结果均显著高于非MG患者。

关键数值与推荐

  • roVEMP递减计算为刺激序列中前2个反应均值与第6至第9个反应均值的比值。
  • roVEMP采用30 Hz刺激范式,单侧递减>9%作为 cutoff。

临床怎么用

  • 作者认为roVEMP可作为MG诊断工具的补充,但不能单独用于OMG诊断。

局限性

  • roVEMP特异度和阳性预测值过低,不能作为单一试验诊断OMG。
  • 区分眼肌型MG与其他神经眼科疾病仍有挑战。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: We developed repetitive ocular vestibular-evoked myogenic potentials (roVEMP) as an electrophysiologic test that allows us to elicit the characteristic decrement of extraocular muscles in patients with ocular myasthenia gravis (OMG). Case-control studies demonstrated that roVEMP reliably differentiates patients with OMG from healthy controls. We now aimed to evaluate the diagnostic accuracy of roVEMP for OMG diagnosis in patients with ptosis and/or diplopia. METHODS: In this blinded prospective diagnostic accuracy trial, we compared roVEMP in 89 consecutive patients presenting with ptosis and/or diplopia suspicious of OMG with a multimodal diagnostic approach, including clinical examination, antibodies, edrophonium testing, repetitive nerve stimulation of accessory and facial nerves, and single-fiber EMG (SFEMG). We calculated the roVEMP decrement as the ratio between the mean of the first 2 responses compared with the mean of the sixth-ninth responses in the train and used cutoff of >9% (unilateral decrement) in a 30 Hz stimulation paradigm. RESULTS: Following a complete diagnostic work-up, 39 patients (44%) were diagnosed with ocular MG, while 50 patients (56%) had various other neuro-ophthalmologic conditions, but not MG (non-MG). roVEMP yielded 88.2% sensitivity, 30.2% specificity, 50% positive predictive value (PPV), and 76.5% negative predictive value (NPV). For comparison, SFEMG resulted in 75% sensitivity, 56% specificity, 55.1% PPV, and 75.7% NPV. All other diagnostic tests (except for the ice pack test) also yielded significantly higher positive results in patients with MG compared with non-MG. DISCUSSION: The study revealed a high sensitivity of 88.2% for roVEMP in OMG, but specificity and PPV were too low to allow for the OMG diagnosis as a single test. Thus, differentiating ocular MG from other neuro-ophthalmologic conditions remains challenging, and the highest diagnostic accuracy is still obtained by a multimodal approach. In this study, roVEMP can complement the diagnostic armamentarium for the diagnosis of MG. CLASSIFICATION OF EVIDENCE: This study provides Class I evidence that in patients with diplopia and ptosis, roVEMP alone does not accurately distinguish MG from non-MG disorders. TRIAL REGISTRATION INFORMATION: ClinicalTrials.gov: NCT03049956.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Valko Y, Wirth MA, Fierz FC, et al. Accuracy of Repetitive Ocular Vestibular-Evoked Myogenic Potentials to Diagnose Myasthenia Gravis in Patients With Ptosis or Diplopia. Neurology. 2024. PMID: 38669629. doi:10.1212/WNL.0000000000209395

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。